VetStem is a pioneering brand in the field of regenerative medicine, dedicated to improving the lives of animals. Since its establishment in 2002, VetStem has been at the forefront of using adipose-derived stem cells for veterinary medicine, setting the standard for the industry. As the first company in the United States to offer this groundbreaking service to veterinarians, VetStem has treated dogs, horses, and cats, revolutionizing their treatment options and outcomes.

With over 70 exclusive licenses for the use of adipose-derived stem cells, VetStem has made significant contributions to the field. They have successfully treated thousands of horses, enabling them to overcome career-ending tendon injuries and return to peak performance. In addition, VetStem has provided effective therapy for dogs suffering from osteoarthritis and orthopedic soft tissue injuries.

VetStem's commitment to advancing regenerative medicine extends beyond their services. They have educated thousands of veterinarians through their in-person and online courses, ensuring that more animals can benefit from this innovative treatment modality. Looking ahead, VetStem continues to explore the potential of stem cell therapy for immune-mediated and inflammatory diseases, organ disease, and failure.

Their collaboration with human medicine partners aims to translate their success in veterinary medicine to advancements in human medical treatments, providing both animals and their owners with a significantly improved quality of life. With their extensive history of innovation, vast expertise, and unwavering dedication to animal welfare, VetStem is the leader in regenerative veterinary medicine